SMMGP - Substance Misuse Management Good Practice

Substance Misuse Management Good Practice

Supporting good practice in drug and alcohol treatment

SMMGP News Archives - 2015

Please note that the older the news item the more likely it is that details such as contact names and addresses, or links to 3rd party web sites, may have changed.

Top of Page
Divider

Opioids Aware: A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain

(Posted 24 November 2015)
"Opioids Aware" is a web-based resource, funded by Public Health England and hosted by the Faculty of Pain Medicine, Royal College of Anaesthetists. In a press release they say...

"There has been a sharp and sustained increase in the prescription of opioid painkillers in recent years. The latest figures from 2014 show that 22.75 million prescriptions were written in England with a total cost of nearly £305 million to the NHS. Similar rises in pr escribing in the US and elsewhere have been accompanied by increases in harms related to these drugs including addiction, unintentional overdose and death. Opioid painkiller problems in the UK have not reached the epidemic proportions seen in the US but we know that over 5% of adults in England and Wales have used opioid medicines that were not prescribed for them in the past year.

Of more concern is that nearly all the rise in prescribing has been for treatment for long-term pain however, opioid medicines are often ineffective for this condition. About 4% of the population in England and Wales is in receipt of a prescription for opioids and once opioids are started they can be difficult to stop.

In the UK and other countries, guidelines for prescribers on the use of opioids have been available but awareness of guidelines and their use has been disappointing. Perhaps the most important message to prescribers is that if medicines (of any sort) do not work for the patient they should be stopped. This is clearly not happening in the case of opioids and patients and prescribers often make the decision to try increasingly high doses. This is almost never helpful and substantially increases the risk of harm from opioids.

Today sees the launch of 'Opioids Aware', a new resource for all prescribers, patients and their carers to support safe and rational use of opioid medicines. The resource has been developed by healthcare professionals and policy groups. Contributions from several medical royal colleges, the Royal Pharmaceutical Society, the British Pain Society, Public Health England, NHS England, NICE, the CQC and the NHS Business Services Authority have helped to ensure that Opioids Aware is relevant for everyone involved in the decision to prescribe and take opioid medicines."

ACCESS THE OPIOIDS AWARE RESOURCE HERE >>>

Top of Page
Divider

"SMMGP News & Updates" Issue #3 (Dec 2015) now online

(Posted 2 December 2015)
This month's combined news, policy and clinical update newsletter "SMMGP News & Updates Issue #3 (Dec 2015)" is now available in the SMMGP Clinical & Policy Updates section in both online and downloadable versions.

If you find SMMGP publications useful please help us continue to produce them. Simply text SMGP01, followed by the amount you would like to donate (£5 or £10), to 70070. Thank you for your support.

If you would like to receive these Updates via e-mail as soon as they are released, please join the SMMGP. Membership is completely free, you can join instantly online, and there are lots of benefits - see the Free SMMGP Membership Application page for more details.

Top of Page
Divider

Online Survey of Codeine Use - Your Help Needed!

(Posted 24 November 2015)
King's College London is currently conducting an online survey concerning codeine use and is seeking help with the recruitment of codeine users...

"The survey contains questions about reasons for codeine use/misuse, types of products being used, sourcing, and substance dependence. The survey has a broad scope as we intent to capture different groups of codeine users, e.g. those struggling with addiction, those taking codeine recreationally. The only two inclusion criteria are: use in the last 3 months of any codeine containing medicine (tablets and syrups) and being over the age of 18."

Any help in recruiting survey participants would be very much appreciated.

ACCESS THE CODEINE USE SURVEY HERE >>>

The study complies with the Data Protection Act and is confidential and anonymous. The study is funded by the EU and carried out here at KCL. The study was approved by Psychiatry, Nursing and Midwifery Research Ethics Subcommittee (PNM RESC), King's College London. The study will be open until 15 January 2016. The overall aim of the study is to collect data about use patterns, risks and dependence to ensure the availability of information and to inform treatment options.

Top of Page
Divider

Call for nominations: SSA Fred Yates prize for Researcher of the Year

(Posted 24 November 2015)
The Society for the Study of Addiction (SSA) is calling for nominations for the Fred Yates prize for Researcher of the Year, "in recognition of a significant contribution to research and practice in the addictions field.

If so you may be eligible for the SSA early/mid-career addiction researcher prize.

CLICK HERE FOR MORE DETAILS AND TO NOMINATE >>>

The prize will be awarded at the annual SSA Symposium to a researcher who is in the early or mid part of her or his career who has made a significant and specific contribution to the addictions field in recent years. The recipient of the prize will receive a cheque for £2,000 and a certificate which includes the words "for a significant contribution to the work of the addictions field". The recipient will be invited to present his or her research at that year's Symposium, for which his or her attendance expenses will be reimbursed, up to a maximum of £500.

Nomination deadline: 31 January, 2016.

Nominees must:

Nominations from SSA members are to be received by 31 January. A selection panel of three individuals is appointed each year from the SSA's Board of Trustees.

Top of Page
Divider

"Widening the availability of naloxone" - New factsheet now online

(Posted 12 November 2015)
A new factsheet has been released by the Department of Health, Medicines & Healthcare products Regulatory Agency, and Public Health England (PHE)...

"Regulations introduced on 1 October 2015 widened the availability of naloxone, a medicine which reverses the effects of a heroin (or other opiate) overdose. This factsheet explains the regulations and how they can be implemented."

The document is available below in Adobe Acrobat PDF format, as well as from the Guidance Documents section and the GOV.UK web site:

Top of Page
Divider

"SMMGP News & Updates" Issue #2 (Nov 2015) now online

(Posted 5 November 2015)
This month's combined news, policy and clinical update newsletter "SMMGP News & Updates Issue #2 (Nov 2015)" is now available in the SMMGP Clinical & Policy Updates section in both online and downloadable versions.

If you find SMMGP publications useful please help us continue to produce them. Simply text SMGP01, followed by the amount you would like to donate (£5 or £10), to 70070. Thank you for your support.

If you would like to receive these Updates via e-mail as soon as they are released, please join the SMMGP. Membership is completely free, you can join instantly online, and there are lots of benefits - see the Free SMMGP Membership Application page for more details.

Top of Page
Divider

"BMA Project Update: Prescribed drugs associated with dependence and withdrawal - building a consensus for action"

(Posted 15 Oct 2015)
The British Medical Association (BMA) Board of Science has released an analysis report entitled "Prescribed drugs associated with dependence and withdrawal - building a consensus for action".

"Prescribing is a major clinical activity and a key therapeutic tool for influencing the health of patients. When certain psychoactive drugs are inappropriately prescribed there is potential for patients to become dependent or suffer withdrawal symptoms, leading to a range of health and social harms. The prescription of a number of these drugs continues to rise mainly because of longer term use, and this issue is becoming increasingly ingrained with complex medical, political and ethical challenges. Too little is known about prescribing patterns, the levels of dependence and withdrawal, and the level of harm that is being caused. There is also too little research about the long-term effects of these drugs. This analysis report has been developed following the Board of Science's call for evidence undertaken in March 2014. It aims to provide a platform for action to improve the prevention, identification and management of dependence and withdrawal associated with prescribed drugs, and has a particular focus on the prescribed use of benzodiazepines, Z-drugs, opioids and antidepressants."

The document is available below as well as from the Other Resources section and the BMA website.

Top of Page
Divider

"SMMGP News & Updates" Issue #1 (Oct 2015) now online

(Posted 7 October 2015)
From membership feedback, we are aware that members prefer receiving information in a "bite-size" and easy-to-read format. For this reason we have combined our popular Policy and Clinical Updates in a single newsletter with additional information relevant to the field and will be sending these out on a monthly basis in future.

We are very pleased to present in the first of the new format newsletter our briefing on the recent changes affecting the supply of naloxone, which includes an example of a policy or protocol which can readily be adapted so that local areas can develop their own version.

The SMMGP News & Updates Issue #1 (Oct 2015) is now available in the SMMGP Clinical & Policy Updates section in both online and downloadable versions.

If you find SMMGP publications useful please help us continue to produce them. Simply text SMGP01, followed by the amount you would like to donate (£5 or £10), to 70070. Thank you for your support.

If you would like to receive these Updates via e-mail as soon as they are released, please join the SMMGP. Membership is completely free, you can join instantly online, and there are lots of benefits - see the Free SMMGP Membership Application page for more details.

Top of Page
Divider

Example "Naloxone Supply Protocol" now online

(Posted 06 October 2015)
Inclusion has kindly allowed SMMGP to share an example of locally agreed policy that reflects the recent changes in legislation regarding the availability of naloxone.

"This protocol aims to provide guidance on the supply of naloxone by Inclusion to service users, family members, hostels, carers and other groups for the purpose of temporarily reversing opioid overdose. This protocol is intended as a framework for the supply of naloxone injections by Inclusion employees and partner agencies within substance misuse services. This protocol applies to all staff volunteers and peers within Substance Misuse services who have direct contact with clients."

The protocol serves as a useful example for any local area wishing to develop their own policies for the supply of naloxone. It can be adapted for any local requirements.

The document is available below in Adobe Acrobat PDF and Microsoft Word formats, as well as from the Guidance Documents section:

Top of Page
Divider

"Take-home naloxone from October 2015" - PHE information now online

(Posted 30 September 2015)
Public Health England (PHE) has published information about the legislation change which, from 1 October 2015, will make naloxone more readily available for those that need it.

"Naloxone, which can be effective in reversing heroin overdoses, is, from the 1 October 2015, more readily available for those that need it. Although naloxone will remain a prescription only medicine, the legislative change will crucially mean people working in drug treatment services are able to supply the drug, without a prescription, to anyone needing it to stop a heroin overdose. In addition to previous legislation, from 1 October 2015:

The document is available below in Adobe Acrobat PDF format, as well as from the Guidance Documents section, and in PowerPoint slide format from the PHE web site:

Note: This document provides summary information about the situation after October 2015 and builds on PHE's February 2015 advice on "Take-home naloxone for opioid overdose in people who use drugs", which still stands.

Top of Page
Divider

SMMGP Advanced Alcohol Course now RCGP Accredited

(Posted 08 September 2015)
SMMGP is delighted to announce that the excellent Advanced Certificate in the Community Management of Alcohol Use Disorders is now accredited by the Royal College of General Practitioners. The RCGP quality mark certifies the course and is associated with the high professional standards that the RCGP embodies.

The Advanced Certificate in the Community Management of Alcohol Use Disorders is designed for GPs, nurses and pharmacists working with people with alcohol use disorders. The certificate will enable participants to advance their skills to "Practitioner with Special Interest" level and is also designed to provide an understanding of local commissioning structures and processes; and the ability to take a leading role in shaping alcohol treatment in primary care. This online course offers the flexibility to work around other commitments, and is self-directed and tutor-led over the course of a year.

Learn more about the advanced course here >>>

For a FREE taster and an introductory overview of the advanced course, access the "SMMGP FreeLearn: Community Management of Alcohol Use Disorders" course on the SMMGP e-Learning web site.

Try the FREE introductory course here >>>

For any other information or to request an application form for the Advanced Certificate in the Community Management of Alcohol Use Disorders please contact megan@morganpengelly.co.uk.

Top of Page
Divider

SMMGP a signatory to "Public-health dangers" letter in The Telegraph

(Posted 01 September 2015)
SMMGP is a signatory to the following letter published in The Telegraph today:

Public-health dangers

SIR - The Government's spending review will determine public expenditure to 2019-20. Again the Government has stressed that it will protect the NHS from cuts. However, this means little while it fails to make a similar commitment on public health.

We write as a group of concerned organisations who are convinced that the NHS will only be sustainable if we prioritise public health - the conclusion also of the NHS Five Year Forward View, which has been backed by the Government.

The public-health budget, distributed to local councils, needs to be protected and indeed increased. Instead, this year the Chancellor made in-year cuts of £200 million.

Cutting public health means cuts to front-line contraceptive and sexual health services, as well as drugs and alcohol services. It also means more diabetes, cancer and heart disease and poorer mental health as we fail to address obesity, smoking and other risks.

We call on the Government to commit itself to increasing the public health budget in real terms, to maintain a ring-fence to ensure such funds are spent on public health, and for Public Health England to be adequately resourced.

Top of Page
Divider

Naloxone - Preliminary advice ahead of next year's updated national clinical guidelines

(Posted 29 July 2015)
An NHS England Patient Safety Alert in 2014 raised questions about naloxone dosing in overdose situations.

There have also been questions about take-home naloxone products that can be supplied and training that should be provided, now and following legislation to make naloxone more widely available from October 2015 onwards.

The 2007 national clinical guidelines are currently being updated and a new edition will be published in 2016. The working group updating the clinical guidelines has decided to publish some preliminary advice on these naloxone questions before addressing its supply and use more fully in the published update next year.

The following open letter from Professor John Strang, chair of the clinical guidelines update working group, is available on the Public Health England Drug and Alcohol website.

The document is also available (in Adobe Acrobat PDF format) from the Other Resources section:

Top of Page
Divider

Free webinar "NICE and general practice: meeting the challenges"

(Posted 28 July 2015)
The National Institute for Health and Care Excellence (NICE) have made their recent webinar "NICE and general practice: meeting the challenges" freely available to watch on demand.

Regsiter here and access the webinar instantly >>>

It's estimated that 1 million patients receive care from a GP or community nurse each day. As primary care faces this increasing demand for services, often with limited resources, family doctors must also meet the unique challenge of applying national guidance to the more personal setting of a GP consultation.

The webinar discusses how NICE can support improvement in the quality of care without placing additional pressures on GPs. Are NICE products useful for primary care, and how does NICE take GPs views into consideration?"

Top of Page
Divider

"Bereaved Through Substance Misuse" - CDAS guidelines now online

(Posted 22 July 2015)
The Centre for Death and Society (CDAS) has produced a set of Guidelines for those whose work brings them into contact with adults bereaved after a drug or alcohol-related death.

The Guidelines are "for all those whose paid or voluntary work brings them into contact with adults bereaved through a drug or alcoholrelated death. By adult we mean any family member, colleague or friend (including those who use drugs and alcohol themselves) bereaved in this way. This easy-to-follow guide shows how best to respond to these bereaved people, enhancing both your work and their well-being."

"The Guidelines are based on the first large scale research project in Britain into the experiences of adults who have been bereaved through a drug or alcohol-related death. The research found that these deaths, not at all unusual in the UK, are particularly difficult to cope with and that those left behind have mixed experiences of the services they have to deal with. While some people reported positive experiences, others experienced poor, unkind, often stigmatising responses, which added to their distress and left them feeling alone, confused, hurt and angry at an already very difficult time. Much poor practice resulted from practitioners not understanding this kind of death and the issues involved."

The guidelines are available on the CDAS website.

They are also available (in Adobe Acrobat PDF format) from the Guidance Documents section:

Top of Page
Divider

SMMGP Future Planning Survey

(Posted 21 July 2015)
SMMGP is changing. Over the last few years we have become the largest independent national organisation that represents not only GPs and primary care, but all disciplines across the drug and alcohol sector. Our membership includes GPs, psychiatrists, pharmacists, drug and alcohol workers, expert patients, non-medical prescribers and others who work in drug and alcohol treatment, the wider health sector, criminal justice, government organisations, providers and other related fields.

To reflect this, we will soon be changing our name to Substance Misuse Management Good Practice.

SMMGP is a recognised expert in the field and has a long history of supporting GPs in drug and alcohol primary care as well as the wider workforce in the sector. We are a registered and independent charity. We work in partnership with the Royal College of General Practitioners and other stakeholders. We believe that the sector is in need of leadership and in future we aim to play our part in unifying the sector as we broaden our scope. We are cognisant of the responsibility to be the voice of our membership. We represent your views on a number of high-level and influential advisory and expert groups.

SMMGP works to promote good practice in drug and alcohol treatment. We provide quality training via our special interest training days and conferences. SMMGP works to influence policy. We believe that policy should minimise drug-related harm, protect rights, promote inclusion and equality and combat stigma. SMMGP provides communication and information via our regular Clinical and Policy Updates, our popular Network newsletter and via our CPD training days. Our extensive website hosts good quality drug and alcohol information and our clinical forums provide a platform for discussion and debate.

We would like to find out how useful our outputs are to you, and/or what you think of them.

!! THE SURVEY IS NOW CLOSED !! - thank you to all those who responded.

Please Note

Thank you for your help.

Top of Page
Divider

SMMGP Policy Update #42 - June 2015 now online

(Posted 17 July 2015)
The SMMGP Policy Update #42 - June 2015 is now available in the SMMGP Clinical & Policy Updates section in both online and downloadable versions.

If you find SMMGP publications useful please help us continue to produce them. Simply text SMGP01, followed by the amount you would like to donate (£5 or £10), to 70070. Thank you for your support.

If you would like to receive these Updates via e-mail as soon as they are released, please join the SMMGP. Membership is completely free, you can join instantly online, and there are lots of benefits - see the Free SMMGP Membership Application page for more details.

Top of Page
Divider

Network #38 now online

(Posted 17 July 2015)
Issue 38 of "Network", the SMMGP Newsletter, is now available to read online, download in Adobe Acrobat PDF format, or browse as a "digital publication" from the Newsletters section in the Resource Library.

The following additional article to accompany Network 38, can be downloaded below in Adobe Acrobat PDF format, as well as from the Other Resources section.

If you find SMMGP publications useful please help us continue to produce them. Simply text SMGP01, followed by the amount you would like to donate (£5 or £10), to 70070. Thank you for your support.

If you would like to receive copies of Network as soon as they are released, please join the SMMGP. Membership is completely free, you can join instantly online, and there are lots of benefits - see the Free SMMGP Membership Application page for more details.

Top of Page
Divider

SMMGP Clinical Update #45 - June 2015 now online

(Posted 16 June 2015)
The SMMGP Clinical Update #45 - June 2015 is now available in the SMMGP Clinical & Policy Updates section in both online and downloadable versions.

If you would like to receive these Updates via e-mail as soon as they are released, please join the SMMGP. Membership is completely free, you can join instantly online, and there are lots of benefits - see the Free SMMGP Membership Application page for more details.

Top of Page
Divider

EMCDDA's Annual Review - "European Drug Report 2015: Trends and Developments"

(Posted 08 June 2015)
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and "new drugs" scene are among the issues highlighted in this years' annual review, which reflects on 20 years of monitoring and examines the global influences and local ramifications of Europe's ever-changing drugs problem.

The report has been published in various languages on the EMCDDA website.

The document is also available (in Adobe Acrobat PDF format) from the Other Resources section:

Top of Page
Divider

"Calling time on missed opportunities: commissioning alcohol services to reduce avoidable harm"

(Posted 21 April 2015)
The paper "Calling time on missed opportunities: commissioning alcohol services to reduce avoidable harm" has been published on the Guidelines in Practice website.

The document is also available (in Adobe Acrobat PDF format) from the Other Resources section:

Disclaimer: The content of this supplement was developed by an expert advisory group convened and supported by Lundbeck Ltd. Lundbeck Ltd provided financial support for meeting costs, honoraria, and administrative support of a medical communications agency, which included medical writing. Lundbeck Ltd has financially supported the publication of this supplement and has reviewed this document for factual accuracy only. The content of this supplement was produced independently of MGP Ltd and Guidelines in Practice. The views and opinions are those of the expert advisory group and not necessarily those of Lundbeck Ltd, or of Guidelines in Practice, its publisher, advisers, or advertisers.

Top of Page
Divider

SMMGP Clinical Update #44 - March 2015 now online

(Posted 07 April 2015)
The SMMGP Clinical Update #44 - March 2015 is now available in the SMMGP Clinical & Policy Updates section in both online and downloadable versions.

If you would like to receive these Updates via e-mail as soon as they are released, please join the SMMGP. Membership is completely free, you can join instantly online, and there are lots of benefits - see the Free SMMGP Membership Application page for more details.

Top of Page
Divider

SMMGP Policy Update #41 - March 2015 now online

(Posted 07 April 2015)
The SMMGP Policy Update #41 - March 2015 is now available in the SMMGP Clinical & Policy Updates section in both online and downloadable versions.

If you would like to receive these Updates via e-mail as soon as they are released, please join the SMMGP. Membership is completely free, you can join instantly online, and there are lots of benefits - see the Free SMMGP Membership Application page for more details.

Top of Page
Divider

ACMD Recovery Committee Survey: "How can we improve or optimise Opioid Substitution Treatment"

(Posted 06 March 2015)
The Advisory Council on the Misuse of Drugs (ACMD) Recovery Committee is seeking information from "experts by experience" on how we can improve treatment for heroin users. Please help the ACMD Recovery Committee by providing answers to 10 simple questions. Your feedback is anonymous.

Please note that this survey is for "experts by experience" only!
You must have been in treatment, or still be in treatment, in order to participate. It is not for "staff professionals" (unless they have been or are in treatment).

Access the ACMD RC online survey here >>>

Top of Page
Divider

Support materials published for drug driving legislation change

(Posted 25 February 2015)
New drug driving legislation is coming into force on 2nd March 2015 and the government awareness campaign to promote the change to the public has now been launched.

To assist pharmacy teams in understanding the implications of the legislation change for patients, the Pharmaceutical Services Negotiating Committee (PSNC) has produced a briefing on it:

The Department of Transport have asked that healthcare professionals help raise awareness with their patients with contractors being asked to display campaign materials (leaflets, stickers, posters, shelf displays, etc.) both in their pharmacies and online or via their social media accounts.

The relevant campaign materials can be downloaded from the PSNC web site.

Pharmacies can register as a campaign partner to order promotional materials free of charge and may find the accompanying partner pack useful for background information.

See also "Guidance for Healthcare Professionals on Drug Driving" in the Guidance Documents section of our site.

Top of Page
Divider

PHE publishes advice on take-home naloxone for opioid overdose in people who use drugs

(Posted 19 February 2015)
Public Health England (PHE) has published advice for commissioners and providers on the provision of take-home naloxone for reversing overdose in people who use heroin and other opiates, now and following legislative change in October 2015 to make naloxone more readily available.

The document is available (in Adobe Acrobat PDF format) from the Guidance Documents section:

The PHE guide lists the free SMMGP e-learning module "SMMGP FreeLearn: Naloxone Saves Lives" as a resource.

Top of Page
Divider

SMMGP supports Naloxone Action Group (NAG England) campaign to make naloxone more accessible

(Posted 19 February 2015)
SMMGP support the Naloxone Action Group (NAG England) campaign to make Naloxone more accessible. Below is the latest NAG England press release:

Why is a life saving, recommended and licensed medicine being ignored?

Experts on heroin use are concerned that drug users and their families in England are being denied access to a life-saving medicine: naloxone, an antidote to heroin overdoses.

The Office for National Statistics have reported that opioid overdose deaths in England have risen by 32% in 2013. Naloxone Action Group England (NAG) are calling for urgent action to ensure that overdose deaths return to the previous downward trend.

There is nothing to prevent those at risk of opiate overdose being prescribed naloxone now, and yet over 50% of local authorities, who are now responsible for commissioning drug treatment in England, do not currently provide it. Scotland and Wales both have national programmes, which are successfully reducing the number of opiate overdoses in those countries.

In May 2012 the Advisory Council on the Misuse of Drugs (ACMD) advised that the Government should ease the restrictions on who can be supplied with naloxone and should investigate how people supplied with naloxone can be suitably trained to administer it in an emergency and respond to overdoses.

The government have now responded to this recommendation and have said that new regulations are being prepared by the Medicines and Healthcare Products Regulatory Agency (MHRA) which will come into effect in October 2015.

John Jolly, Chair of NAG England, said:

"Local authorities in England can already take action to ensure that take home naloxone is made available in their area. But too many areas are failing to provide this life saving medicine and urgent action is needed to ensure wider access for those at risk of overdose, their peers, and families. That is why we are calling for the government to introduce a national programme as there is in the rest of the UK."

You can help by sending your MP a pre-worded e-mail asking them to sign the Early Day Motion 445 which calls on the Government to prioritise the roll-out of Naloxone across the whole of the UK.

Sign up to become a signatory showing your support for the NAG England campaign to make Naloxone more accessible.

Top of Page
Divider

Professor Sir Ian Gilmore Praises SMMGP Alcohol e-Learning Modules

(Posted 06 February 2015)
Professor Sir Ian Gilmore, Chair of UK Alcohol Health Alliance, has commented on the SMMGP Alcohol e-Learning Modules:

"SMMGP has a proud history and has made a real difference to the standard of care for patients with problematic use of alcohol managed in primary care. The e-learning project is a welcome addition and I am delighted to be associated with it. The web-based material is evidence-based, well referenced and presented in a way that makes it easy to learn. I can see real value in this resource for colleagues in primary, secondary and social care - indeed wherever patients with alcohol problems are presenting - and I wish it every success."

Our free-to-access e-learning module "SMMGP FreeLearn: Community Management of Alcohol Use Disorders" is open to anyone who wishes to learn more about management of alcohol use disorders, including how the commissioning process works. It will be of particular interest to GPs, nurses and pharmacists and other primary care practitioners.

The free module also serves as an introduction to our subscription only SMMGP Advanced Certificate in the Community Management of Alcohol Use Disorders.

Top of Page
Divider

SMMGP Launches FREE e-Learning Module: "Community Management of Alcohol Use Disorders"

(Posted 03 February 2015)
SMMGP introduces a brand new free-to-access e-learning module "SMMGP FreeLearn: Community Management of Alcohol Use Disorders" open to anyone who wishes to learn more about management of alcohol use disorders, including how the commissioning process works. It will be of particular interest to GPs, nurses and pharmacists and other primary care practitioners.

Access "SMMGP FreeLearn: Community Management of Alcohol Use Disorders" Now >>>

Dr Steve Brinksman, SMMGP Clinical Lead says:

"SMMGP is pleased to be able to expand the free e-learning we offer with the addition of this Community Management of Alcohol Use Disorders course. It offers an insight into the role primary care services have in working with alcohol users and the vast potential benefits that engaging with this group can have not only on those individuals but their families and wider society. At a time when we need to be ever more aware of the constraints of NHS funding it is important that we engage much earlier with alcohol users to reduce the health harms that impact so heavily upon the NHS."

Rosanna O'Connor, Director or Alcohol, Drugs and Tobacco Division at Public Health England says:

"Around one in five adults is incurring some level of health risk from their use of alcohol. Non-dependent, as well as dependent alcohol misuse, impacts greatly on people's health. It contributes significantly to over 60 conditions including cardiovascular diseases, depression, liver disease and some cancers.

Primary care and other community health services have a key role to play in identifying where patients' use of alcohol may be damaging their health and helping them to reduce their drinking and thereby, reduce the risk of further ill-health. The launch of this new course is timely and PHE is pleased to have been involved in its development."

The e-learning module also serves as an introduction to the subscription only SMMGP Advanced Certificate in the Community Management of Alcohol Use Disorders which was launched in December 2014.

Top of Page
Divider

Adfam's Annual Stakeholders Survey 2015 has been launched!

(Posted 29 January 2015)
Every year Adfam runs a survey, and uses the evidence to review their relationships with their stakeholders. Your feedback is therefore always important, helping to inform them about your needs and what development they can make in the scope of the resources and services they provide.

Everyone who completes the survey has a chance to enter a free prize draw - the winner will receive £50 worth of Adfam publications as a thank you from them.

Please click here to complete the Adfam survey

Top of Page
Divider

SMMGP Clinical Update #43 - December 2014 now online

(Posted 23 January 2015)
The SMMGP Clinical Update #43 - December 2014 is now available in the SMMGP Clinical & Policy Updates section in both online and downloadable versions.

If you would like to receive these Updates via e-mail as soon as they are released, please join the SMMGP. Membership is completely free, you can join instantly online, and there are lots of benefits - see the Free SMMGP Membership Application page for more details.

Top of Page
Divider

SMMGP Policy Update #40 - December 2014 now online

(Posted 23 January 2015)
The SMMGP Policy Update #40 - December 2014 is now available in the SMMGP Clinical & Policy Updates section in both online and downloadable versions.

If you would like to receive these Updates via e-mail as soon as they are released, please join the SMMGP. Membership is completely free, you can join instantly online, and there are lots of benefits - see the Free SMMGP Membership Application page for more details.

Top of Page
Divider

Network #37 now online

(Posted 05 January 2015)
Issue 37 of "Network", the SMMGP Newsletter, is now available to read online, download in Adobe Acrobat PDF format, or browse as a "digital publication" from the Newsletters section in the Resource Library.

If you would like to receive copies of Network as soon as they are released, please join the SMMGP. Membership is completely free, you can join instantly online, and there are lots of benefits - see the Free SMMGP Membership Application page for more details.